Screening for cognitive impairment among patients with systemic lupus erythematosus (SLE) can be challenging; however, some shorter assessments have shown promise for use in the clinical setting.
AMPEL BioSolutions announced the launch of LuGENE®, an exciting breakthrough innovation in systematic lupus erythematosus (SLE) care. LuGENE® is a new blood test designed to predict SLE flares before ...
Systemic lupus erythematosus (SLE) is characterized by autoantibody production, with anti-dsDNA antibodies (anti-dsDNA) being a key indicator for SLE diagnosis and disease monitoring. A new study ...
Credit: Getty Images Understanding the underlying mechanisms and immunological dysfunction of SLE is essential to appreciate its diverse clinical manifestations and guide effective diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results